The contracting authorities, the four regional health trusts would like to enter into work agreements for the delivery of the active ingredient lenalidomide in accordance with Appendix 2 (Requirements Specification). The total contract value is estimated to have a maximum pharmacies' cost price (Norwegian: AIP) of approx. NOK 320 000 000 a year. The contracts must cover the need at all times. Previous consumption in the previous 12 months is only a guideline for the consumption in the pending contract period.

See the attached tender documentation for further information on the contract.